InsiderTrades

Form 4 for CWK Cushman & Wakefield Ltd.

Accepted 2024-05-20 00:00:00 ET · period of report 2024-05-16 · accession 0000950170-24-062561 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-20 2024-05-16 CWK FELMAN MICHELLE Dir M - OptEx $0.00 +12.4K 12.4K New $0
D 2024-05-20 2024-05-16 CWK FELMAN MICHELLE Dir A - Grant $0.00 +15.5K 15.5K New $0
D 2024-05-20 2024-05-16 CWK FELMAN MICHELLE Dir M - OptEx $0.00 -12.4K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2024-05-16 M A 12,393 $0.00 12,393 D — — (F1) Conversion of previously awarded restricted stock units ("RSUs") into an equal number of ordinary shares, without the payment of any consideration, pursuant to the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan.
2 Derivative Restricted Stock Units 2024-05-16 A A 15,451 $0.00 15,451 D — · — to — 15,451 Ordinary Shares (F3) RSUs granted under the Second Amended & Restated 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan convert into an equal number of ordinary shares of Cushman & Wakefield plc. (F4) RSUs were granted on May 16, 2024 and vest and settle on May 16, 2025, subject, with certain limited exceptions, to the reporting person's continuing board service through such vesting date.
3 Derivative Restricted Stock Units 2024-05-16 M D 12,393 $0.00 0 D — · — to — 12,393 Ordinary Shares (F1) Conversion of previously awarded restricted stock units ("RSUs") into an equal number of ordinary shares, without the payment of any consideration, pursuant to the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan. (F2) RSUs were granted on November 2, 2023 and vested and settled on the earlier of (i) November 2, 2024 or (ii) the date of the first annual shareholders' meeting to occur following the grant date subject, with certain limited exceptions, to the reporting person's continuing board service through such vesting date.